Loading
 ดร. หม่อมหลวง มานิดา  สุขสวัสดิ์

ดร. หม่อมหลวง มานิดา สุขสวัสดิ์

คณะแพทยศาสตร์,
มหาวิทยาลัยขอนแก่น
57189389443: H-INDEX 6

บทความ

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance Suksawat, M
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Titapun, A
Koonmee, S
Loilome, W
2017
2. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy. Manida Suksawat
Anchalee Techasen
Nisana Namwat
Thianrut Boonsong
Attapol Titapun
Piti Ungarreevittaya
Puangrat Yongvanit
Watcharin Loilome
2018
3. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy Techasen, A.
Namwat, N.
Titapun, A.
Ungarreevittaya, P.
Yongvanit, P.
2018
4. Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth Hasaya Dokduang
Manida Suksawat
Sureerat Padthaisong
Wassana Jamnongkarn
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Narong Khuntikeao
Watcharin Loilome
2018
5. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues Suksawat, M
Klanrit, P
Phetcharaburanin, J
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Sa-Ngiamwibool, P
Techasen, A
Loilome, W
2019
6. 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination. Phetcharaburanin, J
Deewai, S
Kulthawatsiri, T
Moolpia, K
Suksawat, M
Promraksa, B
Klanrit, P
Namwat, N
Loilome, W
Poopasit, K
Katekaew, S
Phetcharaburanin, P
2020
7. H-1 NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination Jutarop Phetcharaburanin
Suthicha Deewai
Thanaporn Kulthawatsiri
Komkid Moolpia
Manida Suksawat
Bundit Promraksa
Poramate Klanrit
Nisana Namwat
Watcharin Loilome
Kitisak Poopasit
Somporn Katekaew
Penprapa Phetcharaburanin
2020
8. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines Dokduang, H.
Promraksa, B.
Thanee, M.
Phetcharaburanin, J.
Namwat, N.
Titapun, A.
Khuntikeo, N.
Klanrit, P.
Loilome, W.
2020
9. Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits Ho, PN
Klanrit, P
Hanboonsong, Y
Yordpratum, U
Suksawat, M
Kulthawatsiri, T
Jirahiranpat, A
Deewai, S
Mackawan, P
Sermswan, RW
Namwat, N
Loilome, W
Khampitak, T
Wangwiwatsin, A
Phetcharaburanin, J
2021
10. High Levels of Serum IgG for and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. Titapun, A
Luvira, V
Srisuk, T
Jareanrat, A
Thanasukarn, V
Thanee, M
Sa-Ngiamwibool, P
Padthaisong, S
Duangkumpha, K
Suksawat, M
Loilome, W
Sithithaworn, P
Techasen, A
Thinkhamrop, B
Dzienny, A
Caglayan, A
Park, D
Mahmud, S
Khuntikeo, N
2021
11. High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection Titapun, A.
Thanee, M.
Padthaisong, S.
Duangkumpha, K.
Suksawat, M.
Loilome, W.
Sithithaworn, P.
Techasen, A.
Thinkhamrop, B.
Khuntikeo, N.
2021
12. Spirogyra neglecta (Hassall) Kützing attenuates metastasis of castration-resistant human prostate cancer via the blockage of AKT signaling pathway Phetcharaburanin, J. 2021
13. Spirogyra neglecta (Hassall) Kueurotzing attenuates metastasis of castration-resistant human prostate cancer via the blockage of AKT signaling pathway Punnida Arjsri
Jutarop Phetcharaburanin
Manida Suksawat
Sariya Mapoung
Chayaporn Subkamkaew
Warathit Semmarath
Supachai Yodkeeree
Pornngarm Limtrakul Dejkriengkraikul
2021
14. Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models Thanee, M
Padthaisong, S
Suksawat, M
Dokduang, H
Phetcharaburanin, J
Klanrit, P
Titapun, A
Namwat, N
Wangwiwatsin, A
Sa-Ngiamwibool, P
Khuntikeo, N
Saya, H
Loilome, W
2021
15. Therapeutic challenges at the preclinical level for targeted drug development for -associated cholangiocarcinoma. Loilome, W
Dokduang, H
Suksawat, M
Padthaisong, S
2021
16. Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma Loilome, W.
Dokduang, H.
Suksawat, M.
Padthaisong, S.
2021
17. Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. Suksawat, M.
Phetcharaburanin, J.
Klanrit, P.
Namwat, N.
Khuntikeo, N.
Titapun, A.
Techasen, A.
Wangwiwatsin, A.
Mahalapbutr, P.
Loilome, W.
2022
Count 9 10 11 0

Title Authors Year Publication name Cited count
< 2017 2018 2019 2020 2021 2022 รวม
1. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance Techasen, A.
Namwat, N.
Yongvanit, P.
Khuntikeo, N.
Titapun, A.
Koonmee, S.
Loilome, W.
2017 Parasitology International
4 (66), pp. 486-493
2. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy Techasen, A.
Namwat, N.
Titapun, A.
Ungarreevittaya, P.
Yongvanit, P.
2018 FEBS Open Bio
4 (8), pp. 513-522
3. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues Klanrit,
Phetcharaburanin, J.
Khuntikeo, N.
Titapun, A.
Techasen, A.
Loilome,
2019 PLoS ONE
9 (14), pp.
4. In vitro and in vivo anti-tumor effects of pan-her inhibitor varlitinib on cholangiocarcinoma cell lines Dokduang, H.
Promraksa, B.
Thanee, M.
Phetcharaburanin, J.
Namwat, N.
Titapun, A.
Khuntikeo, N.
Klanrit, P.
Loilome, W.
2020 Drug Design, Development and Therapy
(14), pp. 2319-2334
5. Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits Klanrit, P.
Hanboonsong, Y.
Yordpratum, U.
Suksawat, M.
Sermswan, R.W.
Namwat, N.
Loilome, W.
Khampitak, T.
Wangwiwatsin, A.
Phetcharaburanin, J.
2021 Scientific Reports
1 (11), pp.
6. High levels of serum igg for opisthorchis viverrini and cd44 expression predict worse prognosis for cholangiocarcinoma patients after curative resection Titapun, A.
Thanee, M.
Padthaisong, S.
Duangkumpha, K.
Suksawat, M.
Loilome, W.
Sithithaworn, P.
Techasen, A.
Thinkhamrop, B.
Khuntikeo, N.
2021 International Journal of General Medicine
(14), pp. 2191-2204
7. Spirogyra neglecta (Hassall) Kützing attenuates metastasis of castration-resistant human prostate cancer via the blockage of AKT signaling pathway Phetcharaburanin, J. 2021 South African Journal of Botany
(139), pp. 26-37
8. Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma Loilome, W.
Dokduang, H.
Suksawat, M.
Padthaisong, S.
2021 Expert Opinion on Investigational Drugs
9 (30), pp. 985-1006
9. Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma Suksawat, M.
Phetcharaburanin, J.
Klanrit, P.
Namwat, N.
Khuntikeo, N.
Titapun, A.
Techasen, A.
Wangwiwatsin, A.
Mahalapbutr, P.
Loilome, W.
2022 Frontiers in Public Health
(10), pp.

Title Authors Year Journal title
1. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. Suksawat, M
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Titapun, A
Koonmee, S
Loilome, W
2017 Parasitology international
4 (66), pp. 486-493
2. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy. Suksawat, M
Techasen, A
Namwat, N
Boonsong, T
Titapun, A
Ungarreevittaya, P
Yongvanit, P
Loilome, W
2018 FEBS open bio
4 (8), pp. 513-522
3. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. Suksawat, M
Klanrit, P
Phetcharaburanin, J
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Sa-Ngiamwibool, P
Techasen, A
Loilome, W
2019 PloS one
9 (14), pp. e0222140
4. 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination. Phetcharaburanin, J
Deewai, S
Kulthawatsiri, T
Moolpia, K
Suksawat, M
Promraksa, B
Klanrit, P
Namwat, N
Loilome, W
Poopasit, K
Katekaew, S
Phetcharaburanin, P
2020 PloS one
12 (15), pp. e0243432
5. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. Dokduang, H
Jamnongkarn, W
Promraksa, B
Suksawat, M
Padthaisong, S
Thanee, M
Phetcharaburanin, J
Namwat, N
Sangkhamanon, S
Titapun, A
Khuntikeo, N
Klanrit, P
Loilome, W
2020 Drug design, development and therapy
(14), pp. 2319-2334
6. High Levels of Serum IgG for and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. Titapun, A
Luvira, V
Srisuk, T
Jareanrat, A
Thanasukarn, V
Thanee, M
Sa-Ngiamwibool, P
Padthaisong, S
Duangkumpha, K
Suksawat, M
Loilome, W
Sithithaworn, P
Techasen, A
Thinkhamrop, B
Dzienny, A
Caglayan, A
Park, D
Mahmud, S
Khuntikeo, N
2021 International journal of general medicine
(14), pp. 2191-2204
7. Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. Thanee, M
Padthaisong, S
Suksawat, M
Dokduang, H
Phetcharaburanin, J
Klanrit, P
Titapun, A
Namwat, N
Wangwiwatsin, A
Sa-Ngiamwibool, P
Khuntikeo, N
Saya, H
Loilome, W
2021 Cancer & metabolism
1 (9), pp. 11
8. Therapeutic challenges at the preclinical level for targeted drug development for -associated cholangiocarcinoma. Loilome, W
Dokduang, H
Suksawat, M
Padthaisong, S
2021 Expert opinion on investigational drugs
(), pp. 1-22
9. Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits. Ho, PN
Klanrit, P
Hanboonsong, Y
Yordpratum, U
Suksawat, M
Kulthawatsiri, T
Jirahiranpat, A
Deewai, S
Mackawan, P
Sermswan, RW
Namwat, N
Loilome, W
Khampitak, T
Wangwiwatsin, A
Phetcharaburanin, J
2021 Scientific reports
1 (11), pp. 23316
10. Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. Suksawat, M
Phetcharaburanin, J
Klanrit, P
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Vilayhong, V
Sa-Ngiamwibool, P
Techasen, A
Wangwiwatsin, A
Mahalapbutr, P
Li, JV
Loilome, W
2022 Frontiers in public health
(10), pp. 766023

Title Authors Year Journal title Cited count
< 2017 2018 2019 2020 2021 2022 รวม
1. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance Manida Suksawat
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Supinda Koonmee
Watcharin Loilome
2017 PARASITOLOGY INTERNATIONAL
4.0 (66.0), pp. 486.0-493.0
13 0 0 0 0 0 13
2. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy Manida Suksawat
Anchalee Techasen
Nisana Namwat
Thianrut Boonsong
Attapol Titapun
Piti Ungarreevittaya
Puangrat Yongvanit
Watcharin Loilome
2018 FEBS OPEN BIO
4.0 (8.0), pp. 513.0-522.0
7 0 0 0 0 0 7
3. Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth Hasaya Dokduang
Manida Suksawat
Sureerat Padthaisong
Wassana Jamnongkarn
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Narong Khuntikeao
Watcharin Loilome
2018 CANCER SCIENCE
(109.0), pp. 746.0-746.0
0 0 0 0 0 0 0
4. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues Manida Suksawat
Poramate Klanrit
Jutarop Phetcharaburanin
Nisana Namwat
Narong Khuntikeo
Attapol Titapun
Apiwat Jarearnrat
Prakasit Sa-ngiamwibool
Anchalee Techasen
Watcharin Loilome
2019 PLOS ONE
9.0 (14.0), pp.
5 0 0 0 0 0 5
5. H-1 NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination Jutarop Phetcharaburanin
Suthicha Deewai
Thanaporn Kulthawatsiri
Komkid Moolpia
Manida Suksawat
Bundit Promraksa
Poramate Klanrit
Nisana Namwat
Watcharin Loilome
Kitisak Poopasit
Somporn Katekaew
Penprapa Phetcharaburanin
2020 PLOS ONE
12.0 (15.0), pp.
0 0 0 0 0 0 0
6. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines Hasaya Dokduang
Wassana Jamnongkarn
Bundit Promraksa
Manida Suksawat
Sureerat Padthaisong
Malinee Thanee
Jutarop Phetcharaburanin
Nisana Namwat
Sakkarn Sangkhamanon
Attapol Titapun
Narong Khuntikeo
Poramate Klanrit
Watcharin Loilome
2020 DRUG DESIGN DEVELOPMENT AND THERAPY
(14.0), pp. 2319.0-2334.0
2 0 0 0 0 0 2
7. Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits Phuc N. Ho
Poramate Klanrit
Yupa Hanboonsong
Umaporn Yordpratum
Manida Suksawat
Thanaporn Kulthawatsiri
Anyarin Jirahiranpat
Suthicha Deewai
Panya Mackawan
Rasana W. Sermswan
Nisana Namwat
Watcharin Loilome
Tueanjit Khampitak
Arporn Wangwiwatsin
Jutarop Phetcharaburanin
2021 SCIENTIFIC REPORTS
1.0 (11.0), pp.
0 0 0 0 0 0 0
8. High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection Attapol Titapun
Vor Luvira
Tharatip Srisuk
Apiwat Jareanrat
Vasin Thanasukarn
Malinee Thanee
Prakasit Sa-Ngiamwibool
Sureerat Padthaisong
Kassaporn Duangkumpha
Manida Suksawat
Watcharin Loilome
Paiboon Sithithaworn
Anchalee Techasen
Bandit Thinkhamrop
Alexa Dzienny
Ayse Caglayan
David Park
Simran Mahmud
Narong Khuntikeo
2021 INTERNATIONAL JOURNAL OF GENERAL MEDICINE
(14.0), pp. 2191.0-2204.0
0 0 0 0 0 0 0
9. Spirogyra neglecta (Hassall) Kueurotzing attenuates metastasis of castration-resistant human prostate cancer via the blockage of AKT signaling pathway Punnida Arjsri
Jutarop Phetcharaburanin
Manida Suksawat
Sariya Mapoung
Chayaporn Subkamkaew
Warathit Semmarath
Supachai Yodkeeree
Pornngarm Limtrakul Dejkriengkraikul
2021 SOUTH AFRICAN JOURNAL OF BOTANY
(139.0), pp. 26.0-37.0
2 0 0 0 0 0 2
10. Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models Malinee Thanee
Sureerat Padthaisong
Manida Suksawat
Hasaya Dokduang
Jutarop Phetcharaburanin
Poramate Klanrit
Attapol Titapun
Nisana Namwat
Arporn Wangwiwatsin
Prakasit Sa-ngiamwibool
Narong Khuntikeo
Hideyuki Saya
Watcharin Loilome
2021 CANCER & METABOLISM
1.0 (9.0), pp.
2 0 0 0 0 0 2
11. Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma Watcharin Loilome
Hasaya Dokduang
Manida Suksawat
Sureerat Padthaisong
2021 EXPERT OPINION ON INVESTIGATIONAL DRUGS
9.0 (30.0), pp. 985.0-1006.0
0 0 0 0 0 0 0

Title Authors Year Journal title

ชื่อโครงการ Authors ประเภทโครงการ ปีงบประมาณ ทุนวิจับ

0.05274343490600586